积极免疫治疗帕金森病的进展
Daniel Busot1, Haiqiang Yang2, Darrell Sawmiller3,4
1Department of Pharmaceutical Sciences, Taneja College of Pharmacy, University of South Florida, Tampa, FL 33612, USA.
International journal of molecular sciences
|March 14, 2026
概括
活性免疫疗法提供了一种有前途的策略,通过向神经炎症和α-synuclein聚合来修改帕金森病 (PD) 的进展. 树突细胞 (DC) 疫苗显示出清除病态蛋白质和恢复免疫平衡的潜力.
科学领域:
- 神经免疫学 神经免疫学
- 神经退行性疾病 神经退行性疾病
- 疫苗开发 疫苗开发
背景情况:
- 帕金森病 (PD) 涉及多巴胺基神经元损失和α同核蛋白聚合.
- 目前的PD治疗是有症状的,不能阻止疾病的进展.
- 免疫失调和神经炎症是PD病理学的关键因素.
研究的目的:
- 对帕金森病的活性免疫疗法平台进行审查.
- 评估基于树突细胞 (DC) 的疫苗,以增强蛋白质清除和免疫恒常性.
- 确定PD免疫治疗的局限性和未来方向.
主要方法:
- 对当代活性免疫疗法策略的审查:类疫苗,基因疫苗和DC疫苗.
- 对DC疫苗在病理性蛋白质清除和免疫恢复方面的潜力的分析.
- 对转化障碍的评估,包括免疫异质性和血脑屏障.
主要成果:
- 活性免疫疗法,特别是基于DC的方法,显示了PD疾病修饰的潜力.
- DC疫苗提供了增强病态蛋白质清除和恢复免疫平衡的双重好处.
- 在临床应用方面仍然存在重大技术和翻译挑战.
结论:
- 活性免疫疗法代表了帕金森病的有希望的疾病修饰策略.
- 未来的研究应该专注于个性化免疫学分析和先进的DC疫苗配方.
- 针对性疗法,如异形特异性DC粉末疫苗,可以促进α同核素的参与.
相关概念视频
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Active versus Passive Immunity
11.8K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...
11.8K
EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K


